Global Pharmaceutical Glass Tubing Market Outlook Report 2019-2027 –

The "Pharmaceutical Glass Tubing – Global Market Outlook (2019-2027)" report has been added to’s offering.
Global Pharmaceutical Glass Tubing market accounted for $12.35 billion in 2019 and is expected to reach $22.03 billion by 2027 growing at a CAGR of 7.5% during the forecast period.
Growth of the pharmaceutical industry in emerging economies and commodity value of glass increased with recyclability are the major factors driving the market growth. However, increased relevance of alternate sources is restraining the market growth.
Glass is one of the most widely used packaging materials in the pharmaceutical industry. Most of the primary packaging products, such as bottles, ampoules, vials, and syringes, in the industry are made up of the glass material. Pharmaceutical tubing is primarily used as a raw material by the pharmaceutical packaging players to manufacture the end-user primary packaging products.
Based on application, the bottles segment is likely to have a huge demand as glass bottles are among the primary packaging materials used in the pharmaceutical industry. A considerable number of pharmaceutical formulations have been packaged using glass bottles, and they are usually the first choice of packaging materials.
By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to increasing pharmaceutical production in countries such as India and China. Further, manufacturers and suppliers are focusing on shifting their base to China and India, as a result of increasing opportunities offered by the pharmaceutical industry in these countries, especially in the generics sector.
What the report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends Company Profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of COVID-19
4 Porters Five Forces Analysis
4.1 Bargaining Power of Suppliers
4.2 Bargaining Power of Buyers
4.3 Threat of Substitutes
4.4 Threat of New Entrants
4.5 Competitive Rivalry
5 Global Pharmaceutical Glass Tubing Market, By Material Type
5.1 Introduction
5.2 Type I (Borosilicate Neutral Glass)
5.3 Type II (Surface Treated Borosilicate Glass)
5.4 Type III (Soda Lime Glass)
6 Global Pharmaceutical Glass Tubing Market, By Neck Diameter
6.1 Introduction
6.2 Up to 40 mm
6.3 40 mm to 80 mm
6.4 80 mm to 120 mm
6.5 More than 120 mm
7 Global Pharmaceutical Glass Tubing Market, By Application
7.1 Introduction
7.2 Ampoules
7.3 Bottles
7.4 Cartridges
7.5 Syringes
7.6 Vials
8 Global Pharmaceutical Glass Tubing Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia-Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launches
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Accu-Glass LLC
10.2 Aimer Products Limited
10.3 Cangzhou Four-star Glass Co Ltd.
10.4 Corning Incorporated
10.5 DWK Life Sciences GmbH
10.6 LINUO Group
10.7 Nippon Electric Glass Co Ltd.
10.8 Nipro Pharma Corporation
10.9 Puyang New Harmony Industrial Development Co
10.10 Richland Glass Co Inc.
10.11 Schott AG
10.12 Shandong Pharmaceutical Glass Co Ltd.
For more information about this report visit
View source version on
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 01/29/2021 05:09 AM/DISC: 01/29/2021 05:09 AM